Skip to main content
Veterinary Medicines

Nobilis IB + ND + EDS

Authorised
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated

Product identification

Medicine name:
Nobilis IB + ND + EDS
Active substance:
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
  • Newcastle disease virus, strain Clone 30, Inactivated
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Egg drop syndrome '76 virus, strain BC14, Inactivated
    90.50
    unit(s)
    /
    1.00
    Dose
  • Newcastle disease virus, strain Clone 30, Inactivated
    50.00
    unit(s)
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain M41, Inactivated
    64.00
    unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        9999
        day
      • Egg
        no withdrawal period
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA13
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 7998
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."